News

Consulting

Experts to Discuss Pediatric Medicines, Wearables at EuroMeeting 2017

DURHAM, N.C., March 27, 2017 — Two Premier Research drug development experts will speak at the Drug Information Association’s EuroMeeting 2017, March 29-31 in Glasgow: Dr. Thomas Laage, Senior Medical Director, will take part in a session on optimizing development of pediatric medicines on Thursday, March 30, from 11 a.m. to 12:30 p.m. Dr. Laage...

Clinical Research: Phase 1 - Phase 4

Premier Research Launches Electronic Collection of Clinical Trial Patient Data

DURHAM, N.C., MARCH 24, 2017 — Premier Research is launching a smartphone-based patient reported outcome system to replace the paper diaries used in many clinical trials. Premier Mobile ePRO will give sponsors and researchers more accurate and timely patient reported data while reducing the burden on trial participants. “Any study is only as good as...

Consulting

Premier Research Sponsors, Presents at OCT West Coast in February

DURHAM, N.C., February 20, 2017 — Premier Research is a presenting sponsor of this year’s Outsourcing in Clinical Trials West Coast conference in Burlingame, California, and two company executives are speaking at the event. Dr. Colin Hayward, Chief Medical Officer, will speak on moving oncology molecules to proof of concept on Wednesday, February 22, at...

Premier Research Names Nate Thompson Chief Information Officer

DURHAM, N.C., January 4, 2017 — Premier Research announces the appointment of Nate Thompson as Chief Information Officer. Mr. Thompson oversees all information technology initiatives at the global contract research organization as the company implements new systems to more effectively serve its customers in the biotech and specialty pharma industries. Mr. Thompson brings to his...

STARR Coalition Names Premier Research 2016 CRO of the Year

DURHAM, N.C., October 28, 2016 — STARR Coalition, an organization dedicated to treatment, advocacy, research, and recovery in mental health, named Premier Research CRO of the Year at its annual STARR Meeting in Boca Raton, Florida. The group cited Premier Research for its longstanding partnership in supporting the coalition’s mission to serve the mental health...

Quality

The Trends Reshaping Medical Device Trials: Attend Our Webinar on Nov. 2

DURHAM, N.C., OCTOBER 27, 2016 — Medical device and diagnostic companies are conducting more clinical trials than ever, a trend that’s giving rise to new procedures and best practices for studies that differ in many ways from pharmaceutical trials. Register for this webinar focused on the evolution of device clinical research on Wednesday, November 2....

Premier Research Strategist to Discuss Evolving Site Landscape at CNS Summit

DURHAM, N.C., October 26, 2016 — Premier Research’s lead strategist will participate in a panel discussion on the evolving landscape for investigator sites at CNS Summit 2016 in Boca Raton, Florida. Krista Armstrong, Vice President of Strategic Development, will join colleagues in addressing topics such as: Advantages and disadvantages of site consolidation Site selection and strategic...

Other

Premier Research Announces Growth Investment from Metalmark Capital

Investment Will Advance Premier’s Next Development Phase RESEARCH TRIANGLE PARK, N.C., Oct. 17, 2016 — Premier Research (“Premier” or the “Company”), a leading middle-market contract research organization (“CRO”) that provides comprehensive clinical development, analytic, and support services to pharmaceutical, biotech, and medical device customers worldwide, today announced that it will receive a growth investment from...

Patient and Stakeholder Engagement

Strategic Start-Up: Project Managers Addressing MAGI Conference in Las Vegas

DURHAM, N.C., OCTOBER 3, 2016 — You’re starting a lengthy project that’s fraught with risk and could cost a billion dollars or more to complete. A couple of early missteps might spell disaster. Welcome to clinical drug research. Boost your odds of success with a robust project schedule and carefully executed startup plan. At MAGI’s...

Patient and Stakeholder Engagement

Register Now: Patient Advocacy Groups and Their Role in Orphan Drug Development

There are more than 7,000 known rare diseases, and these conditions afflict an estimated 30 million Americans (almost one in 10). Worldwide, some 350 million are living with a rare disease. But for 95 percent of these conditions, there are no FDA-approved treatments — not one. Conventional wisdom holds that innovation follows need: that if...